Patent Expiry

Patent/Exclusivity Expiry: PEMETREXED

March 26, 2035

Company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Drug: PEMETREXED

Other upcoming events for IOVA

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Effica

Patent ExpiryPatent/Exclusivity Expiry: PEMFEXY

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: PEMETREXED — IOVA Patent Expiry | BioSniper